Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.